SNNSmith & Nephew plc

$27.66-22% 1Y

Price

-22%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality mixed, nothing alarming, growing in the filings, the market undecided.

RyuScore 64 of 100: see how it is built
What they do

Smith & Nephew plc (the “Company”) is a public limited company incorporated in England and Wales. In these accounts, the ‘Group’ means the Company and all its subsidiaries. The principal activities of the Group are to develop, manufacture, market and sell medical devices and services. The Group has prepared its accounts in accordance with UK-adopted International Accounting Standards. The Group has also prepared its accounts in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (IASB) effective as at 31 December 2025.

In the company’s own words · 20-F filed Mar 16, 2026 · SEC EDGAR

P/E38.6
Market value$12.78B
1 year-22%
5 years-14%

Charts

As reported to the SEC, without any scoring.

For the full year FY2025, revenue was $6.16B (+6.1% year on year) and net income $625M.

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

10/19 checks · as of Oct 12, 2026

Conflicts between checks are named, never averaged, and thin data says so.